Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

82.92
Delayed Data
As of Jan 15
 +1.56 / +1.92%
Today’s Change
68.25
Today|||52-Week Range
131.95
-5.44%
Year-to-Date
Stock Market News for Jan 12, 2021
Jan 12 / Zacks.com - Paid Partner Content
ALXN or BMRN: Which Is the Better Value Stock Right Now?
Jan 07 / Zacks.com - Paid Partner Content
BioMarin (BMRN) Reveals 1-Year Data on Hemophilia Gene Therapy
Jan 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close81.36
Today’s open81.77
Day’s range81.33 - 83.60
Volume91,699
Average volume (3 months)1,643,143
Market cap$15.1B
Data as of 4:44pm ET, 01/15/2021

Growth & Valuation

Earnings growth (last year)+69.46%
Earnings growth (this year)+3,366.24%
Earnings growth (next 5 years)+51.10%
Revenue growth (last year)+12.63%
P/E ratio18.5
Price/Sales8.98
Price/Book4.78

Competitors

 Today’s
change
Today’s
% change
ZLABZai Lab Ltd+6.97+4.25%
CRSPCRISPR Therapeutics ...-9.99-4.76%
TECHBio-Techne Corp+10.74+3.19%
FATEFate Therapeutics In...-3.86-3.29%
Data as of 5:07pm ET, 01/15/2021

Financials

Next reporting dateFebruary 25, 2021
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$1.7B
Annual profit (last year)-$23.8M
Net profit margin-1.41%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Rafael, California

Forecasts